Waverley Pharma Inc. (FRA:5GZ)
Germany flag Germany · Delayed Price · Currency is EUR
0.0120
0.00 (0.00%)
Last updated: Jan 28, 2026, 3:25 PM CET

Waverley Pharma Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
0.070.240.050.130.160.71
Cash & Short-Term Investments
0.070.240.050.130.160.71
Cash Growth
-71.74%345.02%-60.38%-15.38%-77.75%-51.91%
Accounts Receivable
0.050.050.140.190.420.45
Other Receivables
00.16000.280.01
Receivables
0.060.210.140.190.70.46
Inventory
0.260.2600.060.330.27
Prepaid Expenses
0.010.020.220.240.260.25
Total Current Assets
0.390.730.420.631.451.68
Property, Plant & Equipment
0.230.26----
Goodwill
0.220.22----
Other Intangible Assets
0.340.4-1.681.761.81
Other Long-Term Assets
0.090.430.540.380.48-
Total Assets
1.272.050.952.693.683.49
Accounts Payable
0.410.960.450.721.030.83
Accrued Expenses
---0.170.590.58
Short-Term Debt
2.992.811.60.660.22-
Current Portion of Long-Term Debt
---0.040.04-
Current Portion of Leases
0.040.04----
Other Current Liabilities
00.050.0400.02-
Total Current Liabilities
3.453.862.091.61.891.41
Long-Term Debt
-----0.04
Long-Term Leases
0.190.22----
Total Liabilities
3.644.082.091.61.891.45
Common Stock
777777
Additional Paid-In Capital
0.810.810.810.810.810.81
Retained Earnings
-10.64-10.34-9.4-7.17-6.51-5.71
Comprehensive Income & Other
0.470.50.450.450.49-0.06
Shareholders' Equity
-2.36-2.03-1.141.091.792.04
Total Liabilities & Equity
1.272.050.952.693.683.49
Total Debt
3.223.071.60.70.260.04
Net Cash (Debt)
-3.16-2.83-1.55-0.57-0.10.67
Net Cash Growth
------54.62%
Net Cash Per Share
-0.06-0.05-0.03-0.01-0.000.01
Filing Date Shares Outstanding
545454545454
Total Common Shares Outstanding
545454545454
Working Capital
-3.05-3.13-1.67-0.96-0.450.27
Book Value Per Share
-0.04-0.04-0.020.020.030.04
Tangible Book Value
-2.92-2.65-1.14-0.590.030.23
Tangible Book Value Per Share
-0.05-0.05-0.02-0.010.000.00
Machinery
-0.01----
Source: S&P Global Market Intelligence. Standard template. Financial Sources.